脱毛症の市場規模・シェア・成長分析 (疾患の種類別、治療法別、性別、販売チャネル別、最終用途別、地域別)：産業予測 (2025～2032年)

世界の脱毛症の市場規模は、2023年に87億1,000万米ドルと評価され、予測期間 (2025-2032年) のCAGRは8.0%で、2024年の94億1,000万米ドルから2032年には174億1,000万米ドルに成長する見通しです。

脱毛症治療市場は、改善された有効性と最小限の副作用を持つ高度な毛髪回復薬に対する消費者需要の増加により、大きな成長を遂げています。サイトカイン療法や再生細胞療法などの注目すべき新たな治療法は、細胞の特殊化を促進し、毛髪の成長サイクルを制御することで発毛を促進する能力で人気を集めています。さらに、併用療法が効果的であることが証明されており、現在消費者の間で好まれています。同市場では、多機能成分や、幹細胞治療や低レベルレーザー治療のような発毛を促進する先進治療など、革新的なソリューションの登場が期待されています。市場規模は2024年の94億5,000万米ドルから2032年には181億8,000万米ドルに拡大すると予測されており、脱毛症分野は、レーザーキャップやヘルメットのような革新的な製品によって、力強い拡大が見込まれています。

目次

イントロダクション

• 分析目的
• 市場範囲
• 定義

分析手法

• 情報調達
• 二次・一次データの手法
• 市場規模予測
• 市場の想定と制約

エグゼクティブサマリー

• 市場の概要と展望
• 需給動向の分析
• セグメント別の機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析

市場の主な考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場魅力度指数 (2024年)
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術分析
• 規制分析
• 特許分析
• ケーススタディ

世界の脱毛症の市場規模・CAGR：疾患の種類別 (2025～2032年)

• 市場概要
• 脱毛症エリアタ
• 瘢痕性
• 牽引力
• アンドロゲン性脱毛症

世界の脱毛症の市場規模・CAGR：治療法別 (2025～2032年)

• 市場概要
• 医薬品
• 医療機器

世界の脱毛症の市場規模・CAGR：性別 (2025～2032年)

• 市場概要
• 男性
• 女性

世界の脱毛症の市場規模・CAGR：販売チャネル別 (2025～2032年)

• 市場概要
• 処方箋
• OTC

世界の脱毛症の市場規模・CAGR：最終用途別 (2025～2032年)

• 市場概要
• 在宅医療
• 皮膚科クリニック

世界の脱毛症の市場規模・CAGR (2025～2032年)

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング (2024年)
• 主要企業が採用した戦略
• 市場の近年の動向
• 主要企業の市場シェア (2024年)
• 主要企業のプロファイル
  • 企業概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較 (2022～2024年)

主要企業のプロファイル

• Johnson & Johnson
• Merck & Co.
• Pfizer Inc.
• Cipla Limited
• Dr. Reddy's Laboratories Ltd.
• Sun Pharmaceutical Industries Ltd.
• GlaxoSmithKline plc
• Aclaris Therapeutics, Inc.
• Concert Pharmaceuticals, Inc.
• HCell Inc.
• Follica, Inc.
• Histogen Inc.
• Allergan plc
• Bayer AG
• Kythera Biopharmaceuticals, Inc.
• Polichem S.A.
• Takeda Pharmaceutical Company Limited
• Almirall, S.A.
• Perrigo Company plc
• Vegalab, Inc.

結論と推奨事項

Global Alopecia Market size was valued at USD 8.71 billion in 2023 and is poised to grow from USD 9.41 billion in 2024 to USD 17.41 billion by 2032, growing at a CAGR of 8.0% during the forecast period (2025-2032).

The alopecia treatment market is experiencing significant growth driven by increased consumer demand for advanced hair-restoration medications with improved efficacy and minimal side effects. Notable emerging therapies, such as cytokine therapy and regenerative cell therapy, are gaining traction for their ability to enhance hair regrowth by promoting cellular specialization and regulating the hair growth cycle. Additionally, combination therapies have proven effective and are currently the preferred choice among consumers. The market is expected to see innovative solutions, including multifunctional ingredients and advanced treatments like stem cell therapy and low-level laser therapy, which are enhancing hair regrowth. With a projected market size increase from USD 9.45 Billion in 2024 to USD 18.18 Billion by 2032, the alopecia sector is set for robust expansion, marked by innovative products like laser caps and helmets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Alopecia market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Alopecia Market Segmental Analysis

Global Alopecia Market is segmented by Disease type, Treatment, Gender, Sales Channel, End Use and region. Based on Disease type, the market is segmented into Alopecia Areata, Cicatricial, Traction and Androgenetic Alopecia. Based on Treatment, the market is segmented into Pharmaceuticals and Devices. Based on Gender, the market is segmented into Male and Female. Based on Sales Channel, the market is segmented into Prescriptions and OTC. Based on End Use, the market is segmented into Homecare setting and Dermatology clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Alopecia Market

The global alopecia market is poised for expansion, driven by the increasing prevalence of hair loss conditions. The American Academy of Dermatology Association (AAD) reported that in 2021, approximately 30 million women and 50 million men in the U.S. were affected by alopecia. Notably, around 60% of individuals experience some degree of hair thinning, with pattern hair loss being the most widespread form among both sexes, according to the Journal of Clinical and Diagnostic Research (JCDR). Furthermore, research indicates that 2% of the general population will experience alopecia areata in their lifetime. The rising costs associated with healthcare are propelling the alopecia market forward, particularly due to initiatives from organizations like the American Hair Loss Association and the National Alopecia Areata Foundation, which focus on educating the public about treatment options and hair regrowth strategies. Alopecia areata, like many autoimmune disorders, may have hereditary factors and unknown triggers linked to hair loss. Conditions such as multiple sclerosis, type 1 diabetes, and other autoimmune diseases have shown connections to increased risks for alopecia, further emphasizing the need for awareness and treatment. As public and private campaigns continue to promote awareness and education on alopecia, coupled with the growing statistics on autoimmune diseases and lifestyle factors, the global alopecia market will likely see substantial growth in the coming years.

Restraints in the Global Alopecia Market

The growth of the global alopecia market faces several challenges that may hinder its expansion. One significant restraint is the high cost associated with treatments, which can deter potential consumers. Additionally, in emerging countries, the market will confront obstacles due to inadequate primary care services and insufficient healthcare infrastructure. Furthermore, from 2022 to 2028, stringent regulatory frameworks and low public awareness regarding alopecia and its treatments will further constrain market growth. These factors combined create a challenging environment that could impede the overall advancement of the alopecia market in the coming years.

Market Trends of the Global Alopecia Market

The Global Alopecia market is poised for significant growth, driven by rising incidences of chronic conditions such as arthritis, PCOS, and cancer, along with lifestyle changes and heightened stress levels among populations. The increasing prevalence of hormonal imbalances and unhealthy dietary habits has further fueled demand for effective alopecia treatments, including medications and surgical procedures like hair transplantation. Additionally, an aging population emphasizes the need for targeted solutions in this sector. With substantial market potential in emerging regions, innovative treatment options are expected to shape growth trends, offering lucrative opportunities for stakeholders in the forthcoming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Alopecia Market Size by Disease type & CAGR (2025-2032)

• Market Overview
• Alopecia Areata
• Cicatricial
• Traction
• Androgenetic Alopecia

Global Alopecia Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Pharmaceuticals
• Devices

Global Alopecia Market Size by Gender & CAGR (2025-2032)

• Market Overview
• Male
• Female

Global Alopecia Market Size by Sales Channel & CAGR (2025-2032)

• Market Overview
• Prescriptions
• OTC

Global Alopecia Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Homecare setting
• Dermatology clinics

Global Alopecia Market Size & CAGR (2025-2032)

• North America (Disease type, Treatment, Gender, Sales Channel, End Use)
  • US
  • Canada
• Europe (Disease type, Treatment, Gender, Sales Channel, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Disease type, Treatment, Gender, Sales Channel, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Disease type, Treatment, Gender, Sales Channel, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Disease type, Treatment, Gender, Sales Channel, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aclaris Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Concert Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HCell Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Follica, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Histogen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kythera Biopharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polichem S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Almirall, S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vegalab, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations